DRD Biotech - Crunchbase Company Profile & Funding

Q: When was the last funding round for DRD Biotech?

DRD Biotech closed its last funding round on obfuscated from a Seed round.

Q: How much funding has DRD Biotech raised to date?

DRD Biotech has raised obfuscated.

Overview

DRD Biotech

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About DRD Biotech

CB Rank

968550

DRD developing rapid diagnostic test for the brain damage: Stroke, Concussion.

Founded

obfuscation

Private

Seed

Moscow, Moscow City, Russian Federation

11-50

drdbiotech.com

Biotechnology

Health Diagnostics

Medical Device

Funding Rounds

Seed

OBF

obfuscation

Key People

Jane Alexandrova: Medical Director
Anzhey Zhimbiev: CEO

Details

Legal Name

DRD Biotech, Inc.

Operating Status

Active

Company Type

For Profit

About the Company

Developing a rapid diagnostic test for the brain damage such as Ischemic Stroke, Transient Ischemic Attack, Mild Traumatic Brain Injury, Post-Traumatic Epilepsy, Chronic Brian Ischemia.

Phone Number

7 495 105 99 16

Contact Email

office@drdbiotech.ru

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Rapid test for acute Stroke

An immunochromatographic test system detecting peptides of the NR2 subunit of the NMDA receptor and GFAP protein to diagnose acute stroke.

Rapid test for Cerebral Ischemia

A diagnostic test developed to screen populations at risk for stroke by detecting biomarkers related to cerebral ischemia.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - DRD Biotech	—	obfuscated obfuscation	—	Seed